<table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="tbl2" position="float"><object-id pub-id-type="doi">10.7554/eLife.03604.007</object-id><label>Table 2.</label><caption><p>K<sub>D</sub> values for nucleosides and nucleoside analog drugs calculated from fluorescence titrations</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.03604.007">http://dx.doi.org/10.7554/eLife.03604.007</ext-link></p><p><supplementary-material id="SD1-data"><object-id pub-id-type="doi">10.7554/eLife.03604.008</object-id><label>Table 2&#8212;source data 1.</label><caption><title>Fluorescence data for K<sub>D</sub> calculations.</title><p>For pyrrolo-cytidine and pyrrolo-gemcitabine, individual solutions with fixed nucleoside concentrations and increasing concentrations of vcCNT were prepared, the fluorescence anisotropy was measured, and the data were fit globally to a single-site binding model accounting for ligand depletion. For all other nucleosides, the nucleoside of interest was titrated into solution containing vcCNT and pyrrolo-cytidine 5 &#956;l at a time, the fluorescence anisotropy was measured, and the data were fit globally to a single-site competitive binding model accounting for ligand depletion. All experiments were performed at least three times.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.03604.008">http://dx.doi.org/10.7554/eLife.03604.008</ext-link></p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-03604-data1-v2.xlsx"/></supplementary-material></p></caption><table frame="hsides" rules="groups"><thead><tr><th>Compound</th><th>K<sub>D</sub> (&#956;M)<xref ref-type="table-fn" rid="tblfn2">*</xref></th></tr></thead><tbody><tr><td>uridine</td><td>36 &#177; 3</td></tr><tr><td>cytidine</td><td>61 &#177; 5</td></tr><tr><td>adenosine</td><td>470 &#177; 100</td></tr><tr><td>gemcitabine</td><td>1,370 &#177; 430</td></tr><tr><td>ribavirin</td><td>1,530 &#177; 350</td></tr><tr><td>zebularine</td><td>120 &#177; 5</td></tr><tr><td>3-methyluridine</td><td>520 &#177; 80</td></tr><tr><td>5-fluorouridine</td><td>16 &#177; 1</td></tr><tr><td>5-chlorouridine</td><td>14 &#177; 1</td></tr><tr><td>5-iodouridine</td><td>58 &#177; 5</td></tr><tr><td>5-methyluridine</td><td>61 &#177; 7</td></tr><tr><td>2&#8242;-deoxyuridine</td><td>170 &#177; 10</td></tr><tr><td>3&#8242;-deoxyuridine</td><td>&gt;2,800</td></tr><tr><td>5'-deoxyuridine</td><td>&gt;2,800</td></tr><tr><td>cytarabine</td><td>&gt;3,000</td></tr><tr><td>pyrrolo-cytidine</td><td>0.94 &#177; 0.17</td></tr><tr><td>pyrrolo-gemcitabine</td><td>23.5 &#177; 0.2</td></tr></tbody></table><table-wrap-foot><fn id="tblfn2"><label>*</label><p>Titrations were performed in triplicate and data were fit globally. All values are given as means &#177; SEM. See <xref ref-type="supplementary-material" rid="SD1-data">Table 2&#8212;source data 1</xref> for fluorescence data used in calculating K<sub>D</sub> values.</p></fn></table-wrap-foot></table-wrap>